心血管磁共振在肥厚型心肌病中的应用  

Application of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

作　　者：何荣 邓炜 侯唯姝[1] 李小虎(审校)[1] HE Rong;DENG Wei;HOU Weishu;LI Xiaohu(Department of Radiology,The First Affiliated Hospital of Anhui Medical University,Hefei 230022,China)

机构地区：[1]安徽医科大学第一附属医院医学影像科,合肥230022

出　　处：《国际医学放射学杂志》2024年第5期575-581,共7页International Journal of Medical Radiology

基　　金：安徽省临床医学研究转化项目(202304295107020028)。

摘　　要：肥厚型心肌病(HCM)是最常见的遗传性心脏病,具有遗传、临床表现异质性及预后多样性。心血管磁共振(CMR)不仅能精确地提供丰富的心肌组织信息,还能为临床了解疾病进程、指导临床决策及评估预后提供更多的影像学信息。就心肌扩散成像、血流动力学成像、心肌应变成像及CMR人工智能等CMR技术在HCM早期诊断、鉴别诊断、风险分层、预后评估等方面的应用价值及其局限性进行综述。Hypertrophic cardiomyopathy(HCM)is the most common inherited cardiac disorder,characterized by genetic heterogeneity,diverse clinical manifestations,and varied prognosis.Cardiovascular magnetic resonance(CMR)not only provides detailed myocardial tissue information,but also offers valuable imaging insights for understanding disease progression,guiding clinical decisions,and assessing prognosis.This review discusses the application value and limitations of CMR techniques,including myocardial diffusion imaging,hemodynamic imaging,myocardial strain imaging,and CMR-based artificial intelligence,in the early diagnosis,differential diagnosis,risk stratification,and prognostic evaluation of HCM.

关 键 词：肥厚型心肌病 心血管磁共振 心肌灌注成像 心肌应变成像 心肌扩散成像 四维血流磁共振成像 人工智能 

分 类 号：R542.2[医药卫生—心血管疾病] R445.2[医药卫生—内科学]